Skip to content
10-Q

Quarterly Report

CORE LABORATORIES N.V.

0000950170-23-015365

← back to feed
Filed
Apr 27, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · Apr 21, 2023 46.66M sh
Shares Diluted Q1 2023 · Mar 31, 2023 47.48M sh
Shares Diluted Q1 2023 · Mar 31, 2022 46.3M sh
Stock Repurchased Q1 2023 · Mar 31, 2023 $1K
Stock Repurchased Q1 2023 · Mar 31, 2022 $1.92M
Dividends Paid Q1 2023 · Mar 31, 2023 $466K
Dividends Paid Q1 2023 · Mar 31, 2022 $463K
Capex Q1 2023 · Mar 31, 2023 $2.21M
Capex Q1 2023 · Mar 31, 2022 $2.3M
Operating Cash Flow Q1 2023 · Mar 31, 2023 −$3.17M
Operating Cash Flow Q1 2023 · Mar 31, 2022 $5.29M
Long Term Debt Q1 2023 · Mar 31, 2023 $180.44M
Long Term Debt Q1 2023 · Dec 31, 2022 $172.39M
Cash And Equivalents Q1 2023 · Mar 31, 2023 $16.29M
Cash And Equivalents Q1 2023 · Dec 31, 2022 $15.43M
Stockholders Equity Q1 2023 · Mar 31, 2023 $195.39M
Stockholders Equity Q1 2023 · Dec 31, 2022 $184.26M
Current Liabilities Q1 2023 · Mar 31, 2023 $95.62M
Current Liabilities Q1 2023 · Dec 31, 2022 $103.14M
Current Assets Q1 2023 · Mar 31, 2023 $227.93M
Current Assets Q1 2023 · Dec 31, 2022 $211.7M
Total Assets Q1 2023 · Mar 31, 2023 $593.62M
Total Assets Q1 2023 · Dec 31, 2022 $578.35M
Total Assets Q1 2023 · Mar 31, 2022 $584.92M
Eps Diluted Q1 2023 · Mar 31, 2023 $0.05
Eps Diluted Q1 2023 · Mar 31, 2022 −$0.04
Eps Basic Q1 2023 · Mar 31, 2023 $0.05
Eps Basic Q1 2023 · Mar 31, 2022 −$0.04
Net Income Q1 2023 · Mar 31, 2023 $2.37M
Net Income Q1 2023 · Mar 31, 2022 −$1.89M
Operating Income Q1 2023 · Mar 31, 2023 $6.48M
Operating Income Q1 2023 · Mar 31, 2022 −$391K
Revenue Q1 2023 · Mar 31, 2023 $128.36M
Revenue Q1 2023 · Mar 31, 2022 $115.3M